The IRS values for NIBP, p-p65, p-ERK1/2, and p-JNK1/2 were higher in late CRC stages (TNM III and TNM IV) compared to early stage cancers and adenomas p < 0.05, Table 1). This evidence concerns the gene MAPK8 and adenoma.